机器学习辅助药物重定向框架,用于发现光激酶B抑制剂
George Nicolae Daniel Ion1, George Mihai Nitulescu1, Dragos Paul Mihai1
1Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania.
Pharmaceuticals (Basel, Switzerland)
|January 25, 2025
概括
这项研究使用机器学习寻找现有的药物,可以针对癌症治疗的光激酶B (AurB). 萨雷杜坦,蒙特卢卡斯特和坎尔蒂尼布被确定为潜在的AurB抑制剂.
科学领域:
- 生物化学 生物化学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 极光激酶B (AurB) 是细胞分裂 (线粒分裂) 的一个关键调节者.
- 针对AurB是一种有前途的癌症治疗策略.
- 在临床使用中需要有效的AurB抑制剂.
研究的目的:
- 使用药物重定向方法识别潜在的光激酶B (AurB) 抑制剂.
- 开发和验证用于药物发现的机器学习框架.
主要方法:
- 使用了一种机器学习管道,结合了QSAR建模,分子指纹,分子对接和分子动力学 (MD) 模拟.
- 从DrugBank数据库中选了4680种药物,以寻找潜在的aurB抑制活性.
主要成果:
- 确定了saredutant,蒙特卢卡斯特和canertinib作为潜在的AurB抑制剂.
- 沙雷杜坦是一种NK2抗剂,与AurB.AurB.表现出强大的结合亲和力和稳定的相互作用.
- 计算分析证实了确定候选物的有利的结合能和分子动态.
结论:
- 该研究成功地通过计算药物重定位识别了aurB抑制的新药候选者.
- 集成机器学习方法在发现对具有挑战性的药物标的抑制剂方面是有效的.
- 沙雷杜坦被强调为一个有前途的化合物,以进一步研究作为AurB抑制剂.
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


